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Rural Health Clinical Pharmacist
rural h e a lth  n e tw o rk
S W O S U  C O L L E G E  O F  P H A R M A C Y
Rural Health Network
• Our purpose is to elevate rural healthcare by tunneling information, 
developing services and assisting rural pharmacists in the 




• Pharmacy and Hospital Visits
• Mission Trip
• Ipad Medication Use Counseling videos
• Rural Health Network Website and Resources
• http://www.swosu.edu/academics/pharmacy/rhn/index.aspx
• Remote Medication Order Processing
• Transitional Care Medication Reconciliation Discharge Counseling
• Medication Therapy Management
Rural Healthcare
• Rural residents have access to fewer healthcare services, 
lower economic and insurance status, fewer physicians per 
capita, and higher chronic disease rates than their urban 
peers.
• In the past year alone, more rural hospitals closed than in the 
prior 15 years combined.
Maintaining long-term viability of critical access hospitals 
(CAH) will be essential for rural healthcare delivery.
Medicare Beneficiary Quality 
Improvement Project
Critical Access Hospitals &  Small Hospital Improvement Program Grantees in Oklahoma
2013
Adverse Drug Events
• Account for 34.2 %  of all hospital acquired conditions.
• Each hospitalized patient on average is subjected to more
than one medication error per day.
• Processing a prescription drug order through a 
Computerized Provider Order Entry (CPOE) system cuts 
the likelihood of error on that order by 48%.
MBQIP Meaningful Use 
Phase 3 Measure
• Pharmacist CPOE/Verification of Medication Orders within 24 
hours
• Numerator: Number of electronically entered medication orders 
for an inpatient admitted to a CAH (acute or swing-bed), verified 
by a pharmacist or directly entered by a pharmacist within 24 
hours
• Denominator: Total number of electronically entered medication 
orders for an inpatient admitted to CAH (acute or swing-bed) 
during the reporting period
• Inclusion/Exclusion Criteria:
• Included: Inpatients admitted to acute care bed, swing bed; 
observation patients
• Excluded: Outpatients; ED patients
Pharmacist Verification Report
> Generated by your computerized pharmacy system or 
electronic health record (EHR).
• Minimum data elements in report should include:
• Date for each order
• Time ordered
• Time verified (or "no verification required" because it was 
entered by the pharmacist)
• Total number of orders verified or entered by pharmacist within 
24 hours




• Serves small rural hospitals in Oklahoma
• Reviews medication orders remotely for contracted hospitals 
in the absence of a pharmacist
• Hospital Drug Room--152 in Oklahoma
• Consultant Pharmacist--52 visits per year
• All orders reviewed within 24 hours, 7 days a week
• Appropriateness of drug, dose, route, frequency, allergies and 
other drug or disease interactions
• Clinical knowledge for review of inpatient chart
Adverse Drug Events
• Defined as harm experienced by a patient as a result of exposure to 
a medication
• Account for nearly 700,000 emergency department visits and 
100,000 hospitalizations each year
• Affect nearly 5% of hospitalized patients, making them one of the 
most common types of inpatient errors
By detecting and preventing adverse drug events, a hospital can 
reduce expenses while providing better quality care to its patients.
STAGE SAFETY STRATEGY
Prescribing • Avoid unnecessary medications by adhering to conservative prescribing principles
• Computerized provider order entry, especially when paired with clinical decision support 
systems
• Medication reconciliation at times of transitions in care
Transcribing • Computerized provider order entry to eliminate handwriting errors
Dispensing • Clinical pharmacists to oversee medication dispensing process
• Use of "tall man" lettering and other strategies to minimize confusion between look-alike, 
sound-alike medications
Administration • Adherence to the "Five Rights" of medication safety (administering the Right Medication, in the
Right Dose, at the Right Time, by the Right Route, to the Right Patient)
• Barcode medication administration to ensure medications are given to the correct patient
• Minimize interruptions to allow nurses to administer medications safely
• Smart infusion pumps for intravenous infusions
• Patient education and revised medication labels to improve patient comprehension of 
administration instructions
*Table provided by Agency for Healthcare Research and Quality Patient Safety Network ©2013
Southwestern Oklahoma State University College of Pharmacy 
Remote Medication Order Processing Pharmacy 
Policy and Procedure Manual 
Table of Contents
• Compliance with Federal and State Laws and Regulations
• Minimum Technical Standards and Specifications
• Confidentiality, Privacy and Security and General Issues
• Pharmacist Training, Orientation, and Competencies
• Workload Balancing and Staffing Levels
• Drug Information Resources
• Communication and Problem Resolution
• Quality Assurance and Medication Error Reporting Systems
• Medication Errors
• Pharmacist Order Verification and Exceptions
• Medication Orders
• Questionable Medication Orders
• Pharmacist Therapeutic Intervention
• Creatinine Level Assessment
• Renal Dosing Adjustments
• Performance Improvement Plan
• Record Keeping, Reports, Annual Review, Documentation
• Pharmacist Consult Form
• Potential Adverse Drug Reaction Form
• Adverse Drug Reaction Reporting Form
Adverse Drug Reaction 
Reporting Form
Date of Reaction: _____________________  Known A lle rg ies :_______________________
Suspected Drug: ___________________________________________________  Start Date:
Concurrent Drugs: ______________________________________________________________
Describe Reaction: ______________________________________________________________
Circle all that apply: Gi SKIN CV CNS LABS OTHER
Nausea Rash Hypertension Headache LFTs Short of Breath
Vom iting Itching Hypotension Confusion Scr/BUN Wheezing
Diarrhea Flushing Chest Pain Anxiety Neutropenia Fever
Constipation Swelling Arrhythmias Sedation Anemia Chills
GI Upset Phlebitis Bradycardia Depression Electrolyte Seizures
G I Pain Erythema Tachycardia Malaise Shock
W as the Physician Notified: □  Yes □  No
T reatment o f reaction: (Circle or list drugs prescribed or actions taken.)
Discontinued drug 
Decrease dose 



















1. W as the drug involved in the A D R  inappropriate for the patient’s  clinical condition?
2. Were the dose, route and frequency of administration appropriate for the patient’s  age, weight, organ function and disease 
state?
3. If the reaction w as due to a drug allergy, w as this allergy previously documented?
□  Admitting orders □  Pharmacy computer □  Nursing Kardex
4. Were appropriate therapeutic drug monitoring or other laboratory tests performed, which may have predicted this reaction? 
(include toxic serum levels)
5. Reaction involved a drug-drug, drug-food or drug-lab interaction.
SEVERITY ASSESSMENT
1. An A D R  occurred but required no change in treatment with the suspected drug.
2. The A D R required that treatment with the suspected drug be held, discontinued or otherwise changed. No antidote or other 
treatment required. No increase in length of stay.
3. The A D R required that treatment with the suspected drug be held, discontinued or otherwise changed A N D /O R  an antidote or 
other treatment w as required.
4. Serious A D R , but drug’s  benefits outweigh the adverse effects; drug is continued.
5. The A D R was the reason for admission.
6. The A D R treatment required intensive medical care. Increase length of stay.
7. The A D R caused permanent harm to the patient.
8. The A D R directly or indirectly led to the death of the patient.
THESE TYPES OF ADR ARE REPORTABLE TO THE FDA - MED WATCH
1. The suspected drug has been on the market for less than two years.
2. The reaction is not listed in the package insert.
3. The reaction is attributed to an investigational drug.
4. The reaction contributed to the death of the patient.
5. The reaction was life-threatening or permanently disabling.
This information will remain confidential. Upon completion of the form, return to the ____________________  Department.
Completed by: Date:
Pharmacist Intervention Form
Initiated by: , RPH , MD
, RN Other
Patient Name: Room #: Medical Record #:
• Nature of Consult: Date/Time:____
Order clarification required (omission of dose, route, etc.)__________
• Dosing is too FREQUENT/INFREQUENT
• Medication:_____________  Dosing Interval:______________
Duration of therapy too PROLONGED/PROTRACTED________________
• Potential drug-drug INTERACTION/INCOMPATIBILITY
Drugs involved:_____________________________
• Potential need to change medications secondary to allergy history
Allergy:___________  Medication:____________
• Questionable indication for use
Indication:______________  Medication:______________
• Alternative agent recommended in view of patient's condition.
(Include IV to PO as less costly therapeutic alternative)




Drug information requested (briefly describe)_____________________
Other/further explanation:_______________________
• OUTCOME OF CONSULT
□  Order clarified/drug information provided
□  Change made according to Pharmacist's suggestion
□  Justification by physician acceptable to Pharmacist
□  Case resolved, forward to Pharmacy and Therapeutics Committee
Date/Time Resolved:________
• Pharmacist:_____________  Date:________
2014 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
T o ta l H ours P h a rm a c ist on D u ty
T o ta l N u m b e r o f O rd e rs  R e v ie w e d
T o ta l N u m b e r o f O rd e rs  E n te re d
P o te n tia l D rug In te ra c tio n s  C o m m u n ic a te d 1
T o ta l N u m b e r o f In te rv e n t io n s
Breakdown
M e d ica tio n  E rro rs2
T ra n sc rip t io n  Errors
M e d ica tio n  Error R a te 3
O rd e r c la r if ic a t io n s4
T h e r a p e u t ic  C h a n g e  R e c o m m e n d a t io n s5
T h e r a p e u t ic  M o n ito rin g  R e c o m m e n d a t io n s6
D o sin g  Is s u e s7
R e q u e st fo r  O rd e rs8
R e q u e st fo r  A d d it io n a l In fo rm a tio n 9
1 This is a service to make the practioner aw are of potential drug interactions that can occur due to multiple medications that the patient is taking and to indicate how the adverse result may present.
2 Many of these errors are transcription errors involving a w rong medication, dosage form, dose, frequency, route of administration, or scheduling w hen the medication is entered into the computer system or onto 
the MAR. The errors may or may not have been corrected prior to the first dose given and therefore may or may not have resulted in an actual medication error involving the patient.
3 Number of medication errors as a per cent of total number or orders reviewed. (Not total number of doses.)
4
These result w hen there is inadequate information contained in the physician's order. More information is needed to complete entry into the computer system or review of the order previously entered. 
Pharmacists also use this to communicate the need for home medications to be brought from home as w ell as any automatic substitutions that may have been used during order entry.
5 These result w hen there is a therapeutic or economic reason to change an order. (ex. Duplicate therapy, change of route from V  to oral, etc.)
6 These result w hen a high dose or drug potentiation merits monitoring clinical lab values or vitals.
7 Such as exceeding maximum recommended dose, inappropriate frequency or route of administration.
8 Results w hen medication administration record indicates an order entered w ithout the faxed order available for review. (a performance improvement monitor)
9 Includes discussion such as patient allergies, lab values, age, weight, etc.
Transitional Care
• Care transitions are complex and vulnerable to medical error, 
especially adverse drug events
• Occur when a patient moves from one health care provider or 
setting to another
• Nearly 1 in 5 Medicare patients discharged from a hospital is 
readmitted within 30 days
• Of the 1.5 million medication errors that harm patients each 
year, approximately 60% occur during transitions of care.
The Joint Commission's National Patient Safety Goals require 
health care organizations to "accurately and completely 
reconcile medications across the continuum of care."
Transitional Care
• Nearly two-thirds of post-discharge adverse events are 
medication related
• 29% of these adverse drug events (ADE's) are serious or life 
threatening, resulting in emergency department visits and 
unscheduled hospital admissions
• As many as 60% of post discharge ADE's could be prevented 
with intervention by health care professionals at discharge or 
shortly thereafter
• Preventable ADE's resulting in hospital admissions are 
estimated to increase the cost of care to the health system by 
$3.8 million per year, with nonadherence being the main 
cause for ADE admissions
Role of the Pharmacist




• Follow-up telephone calls
• Results in identification and resolution of medication 
discrepancies
• Reduces the incidence of preventable adverse drug events 
after discharge




• Handoff from Transitional Care to the pharmacy
• Continuity of information transfer
• Keeps pharmacy updated on current treatment
• Enhances patient understanding
• Focuses on Patient Centered Care
• Complete Medication Review
• Target Interventions
• Patient Adherence




• Performing necessary assessments of the patient's health status;
• Formulating a medication treatment plan;
• Selecting, initiating, modifying, or administering medication therapy;
• Monitoring and evaluating the patient's response to therapy, including safety and effectiveness;
• Performing a comprehensive medication review to identify, resolve, and prevent medication-related 
problems, including adverse drug events;
• Documenting the care delivered and communicating essential information to the patient's other 
primary care providers;
• Providing verbal education and training designed to enhance patient understanding and appropriate use 
of his/her medications;
• Providing information, support services and resources designed to enhance patient adherence with 
his/her therapeutic regimens;
• Coordinating and integrating medication therapy management services within the broader health care- 
management services being provided to the patient.
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